Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer

J Clin Oncol. 2005 Nov 20;23(33):8544-6; author reply 8546-7. doi: 10.1200/JCO.2005.03.7416.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Decision Support Techniques*
  • Female
  • Humans

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors